Open
PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales — Eligibility Criteria
Eligibility
PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales is open to startups registered in India. The full eligibility criteria — qualifying sectors, states and entity types — are below.
Who can apply
Who can apply
- Manufacturers of critical KSMs, DIs and APIs that are registered in India.
- The project must be greenfield — a new manufacturing facility built from the ground up. Extending or upgrading an existing plant does not qualify.
- Applicants must commit a threshold investment that varies by product segment, ranging from ₹20 crore to ₹400 crore.
Beyond these points, eligibility rests on the product being manufactured, the greenfield nature of the facility and the investment committed.
PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales is open to startups at any stage working in health lifesciences. It is open to startups registered anywhere in India. Applicants should be registered as private limited, llp and opc.
health lifesciences
- Eligible stage
- Any stage
- Location
- Open to startups registered in India
- Entity type
- Private Limited, Llp, Opc, Partnership, Proprietorship
← Back to PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales overview